GUILLERMO OVIDIO
VILLA VALDES


Imperial College London
Londres, Reino UnidoPublications in collaboration with researchers from Imperial College London (5)
2023
-
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI
Cardiovascular Drugs and Therapy, Vol. 37, Núm. 5, pp. 941-953
-
Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI study
The Lancet Regional Health - Europe, Vol. 31
2022
-
Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 8, Núm. 4, pp. 447-460
2017
-
Cost-effectiveness of evolocumab therapy for reducing cardiovascular events in patients with atherosclerotic cardiovascular disease
JAMA Cardiology, Vol. 2, Núm. 10, pp. 1069-1078
-
Prediction of cardiovascular risk in patients with familial hypercholesterolaemia
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 3, Núm. 4, pp. 274-280